Improving prediction of blood clots in cancer patients
Novel approaches to improve prediction of cancer-associated thrombosis
This study is looking to find better ways to predict blood clots in cancer patients so that those at higher risk can get the right preventive treatments to stay safe.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cleveland Clinic Lerner Com-Cwru NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-10456311 on NIH RePORTER |
What this research studies
This research focuses on understanding and predicting venous thromboembolism (VTE), a serious condition where blood clots form in patients with cancer. The study aims to identify high-risk patients who may benefit from preventive treatments by developing new biomarkers that can more accurately predict VTE risk. It involves a two-phase approach: first discovering novel biomarkers related to blood clotting and then validating their effectiveness in predicting VTE. By enhancing risk prediction, the research seeks to optimize treatment strategies for cancer patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients who may be at risk for developing venous thromboembolism.
Not a fit: Patients who do not have cancer or those who are not at risk for blood clots may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better identification of cancer patients at risk for blood clots, allowing for more effective prevention strategies.
How similar studies have performed: Previous research has shown promise in identifying biomarkers for blood clot risk, but this approach aims to innovate beyond existing methods.
Where this research is happening
Cleveland, United States
- Cleveland Clinic Lerner Com-Cwru — Cleveland, United States (Active)
Researchers
- Principal investigator: Mccrae, Keith R. — Cleveland Clinic Lerner Com-Cwru
- Study coordinator: Mccrae, Keith R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.